Fmr Llc

Insider Reports History

Entity: Company
Location: 245 Summer Street, Boston, MA
Signature: /s/ Stephanie J. Brown, Duly authorized under Powers of Attorney, by and on behalf of FMR LLC and its direct and indirect subsidiaries, and Abigail P. Johnson
All insider transactions: Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Fmr Llc:

Stock	Role	Class	Num Shares	Value	Price $	Report Date	Ownership
Flywire Corp	Other*	Common Stock	7.27M	$135M	$18.58	May 28, 2021	F-Prime Capital Partners Tech Fund LP
Toast, Inc.	Other*	Class B Common Stock	6.7M	$113M	$16.92	Nov 9, 2021	F-Prime Capital Partners Tech Fund LP
Neumora Therapeutics, Inc.	Other*	Common Stock	5.47M	$65.6M	$11.98	Sep 19, 2023	F-Prime Capital Partners Life Sciences Fund VII LP
Prime Medicine, Inc.	Other*	Common Stock	4.23M	$63.3M	$14.97	Oct 24, 2022	Entity managed by Impresa Management LLC whose shares are subject to reporting by the Undersigned
Prime Medicine, Inc.	Other*	Common Stock	4.12M	$61.7M	$14.97	Oct 24, 2022	F-Prime Capital Partners Life Sciences Fund VI LP
Structure Therapeutics Inc.	Other*, 10%+ Owner	American Depositary Shares	1.54M	$47.1M	$30.54	Feb 6, 2025	Shares held by persons and entities whose shares are subject to reporting by the undersigned
Beam Therapeutics Inc.	Other*, 10%+ Owner	Common Stock	2.12M	$37.6M	$17.73	Mar 31, 2025	Shares held by persons and entities whose shares are subject to reporting by the undersigned.
Beam Therapeutics Inc.	Other*, 10%+ Owner	Common Stock	1.14M	$20.2M	$17.73	Mar 31, 2025	F-Prime Capital Partners Healthcare Fund V LP
Bicara Therapeutics Inc.	Other*	Common Stock	1.12M	$14.8M	$13.24	Sep 16, 2024	F-Prime Capital Partners Life Sciences Fund VII LP
Rallybio Corp	Other*	Common Stock	1.69M	$13.9M	$8.20	Aug 2, 2021	F-Prime Capital Partners Life Sciences Fund VI LP
Sana Biotechnology, Inc.	Other*, 10%+ Owner	Common Stock	4.54M	$7.49M	$1.65	Jan 8, 2025	F-Prime Capital Partners Life Sciences Fund VI LP
Verve Therapeutics, Inc.	Other*	Common Stock	571K	$5.71M	$10.00	Jul 26, 2022	F-Prime Capital Partners Healthcare Fund V LP
Caribou Biosciences, Inc.	Other*	Common Stock	1.84M	$5.45M	$2.96	Jul 27, 2021	F-Prime Capital Partners Healthcare Fund IV LP
Caribou Biosciences, Inc.	Other*	Common Stock	1.46M	$4.34M	$2.96	Jul 27, 2021	Impresa Fund III Limited Partnership
Prime Medicine, Inc.	Other*	Common Stock	110K	$1.65M	$14.97	Oct 24, 2022	F-Prime Capital Partners Life Sciences Advisors Fund VI LP
Xilio Therapeutics, Inc.	Other*	Common Stock	1.53M	$1.27M	$0.83	Oct 26, 2021	F-Prime Capital Partners Healthcare Fund IV LP
Neumora Therapeutics, Inc.	Other*	Common Stock	88.3K	$1.06M	$11.98	Sep 19, 2023	FBRI LLC
Neumora Therapeutics, Inc.	Other*	Common Stock	63.7K	$763K	$11.98	Sep 19, 2023	F-Prime Inc.
Structure Therapeutics Inc.	Other*, 10%+ Owner	American Depositary Shares	16.1K	$491K	$30.54	Feb 6, 2025	F-Prime Capital Partners Life Sciences Fund VI LP
Xilio Therapeutics, Inc.	Other*	Common Stock	372K	$309K	$0.83	Oct 26, 2021	Impresa Fund III Limited Partnership
Caribou Biosciences, Inc.	Other*	Common Stock	17.6K	$52K	$2.96	Jul 27, 2021	F-Prime Capital Partners Healthcare Advisors Fund IV LP
Structure Therapeutics Inc.	Other*, 10%+ Owner	American Depositary Shares	1.37K	$41.7K	$30.54	Feb 6, 2025	F-Prime Capital Partners Life Sciences Advisors Fund VI LP
Fidelity Private Credit Fund	Other*	Class D Common Shares of Beneficial Interest	398	$10.2K	$25.54	Jan 29, 2024	FMR Capital Inc.
Fidelity Private Credit Fund	Other*	Class S Common Shares of Beneficial Interest	398	$10.2K	$25.54	Jan 29, 2024	FMR Capital Inc.
Beam Therapeutics Inc.	Other*, 10%+ Owner	Common Stock	473	$8.39K	$17.73	Mar 31, 2025	FMR Capital, Inc.
Xilio Therapeutics, Inc.	Other*	Common Stock	4.47K	$3.71K	$0.83	Oct 26, 2021	F-Prime Capital Partners Healthcare Advisors Fund IV LP
Sana Biotechnology, Inc.	Other*, 10%+ Owner	Common Stock	61	$101	$1.65	Jan 8, 2025	FMR Capital, Inc.
Structure Therapeutics Inc.	Other*, 10%+ Owner	American Depositary Shares	0	$0	$30.54	Feb 6, 2025	FIMM, LLC
Metsera, Inc.	Other*, 10%+ Owner	Common Stock	4.54M			Feb 3, 2025	F-Prime Capital Partners Life Sciences Fund VIII LP
Fidelity Multi-Strategy Credit Fund	Other*, 10%+ Owner	Common Shares of Beneficial Ownership	2.5M			May 19, 2023	Direct
Fidelity Private Credit Fund	Other*	Class I Common Shares of Beneficial Interest	1.28M			Jan 29, 2024	Direct
Turnstone Biologics Corp.	Other*	Common Stock	833K			Jan 9, 2024	F-Prime Capital Partners Healthcare Fund V LP
Structure Therapeutics Inc.	Other*, 10%+ Owner	Ordinary Shares	531K			Feb 6, 2025	F-Prime Capital Partners Life Sciences Fund VI LP
Fidelity Private Credit Fund	Other*	Class I Common Shares of Beneficial Interest	352K			Jan 29, 2024	Fidelity Multi-Strategy Credit Fund
Turnstone Biologics Corp.	Other*	Common Stock	296K			Jan 9, 2024	Impresa Fund III Limited Partnership
Structure Therapeutics Inc.	Other*, 10%+ Owner	Ordinary Shares	45.1K			Feb 6, 2025	F-Prime Capital Partners Life Sciences Advisors Fund VI LP
Turnstone Biologics Corp.	Other*	Common Stock	4.94K			Jan 9, 2024	F-Prime Capital Partners Healthcare Advisors Fund V LP
Fidelity Private Credit Fund	Other*	Class I Common Shares of Beneficial Interest	86.1			Jan 29, 2024	FMR Capital Inc.
Bicara Therapeutics Inc.	Other*	Series B Preferred Stock	0			Sep 16, 2024	F-Prime Capital Partners Life Sciences Fund VII LP
Bicara Therapeutics Inc.	Other*	Series C Preferred Stock	0			Sep 16, 2024	F-Prime Capital Partners Life Sciences Fund VII LP
Bicara Therapeutics Inc.	Other*	Series Seed Preferred Stock	0			Sep 16, 2024	F-Prime Capital Partners Life Sciences Fund VII LP
Caribou Biosciences, Inc.	Other*	Series A-1 Preferred Stock	0			Jul 27, 2021	F-Prime Capital Partners Healthcare Advisors Fund IV LP
Caribou Biosciences, Inc.	Other*	Series A-1 Preferred Stock	0			Jul 27, 2021	F-Prime Capital Partners Healthcare Fund IV LP
Caribou Biosciences, Inc.	Other*	Series A-1 Preferred Stock	0			Jul 27, 2021	Impresa Fund III Limited Partnership
Caribou Biosciences, Inc.	Other*	Series B Preferred Stock	0			Jul 27, 2021	F-Prime Capital Partners Healthcare Fund IV LP
Flywire Corp	Other*	Series A Preferred Stock	0			May 28, 2021	F-Prime Capital Partners Tech Fund LP
Flywire Corp	Other*	Series B-1 NV Preferred Stock	0			May 28, 2021	F-Prime Capital Partners Tech Fund LP
Flywire Corp	Other*	Series B-1 Preferred Stock	0			May 28, 2021	F-Prime Capital Partners Tech Fund LP
Flywire Corp	Other*	Series B Preferred Stock	0			May 28, 2021	F-Prime Capital Partners Tech Fund LP
Flywire Corp	Other*	Series C Preferred Stock	0			May 28, 2021	F-Prime Capital Partners Tech Fund LP

Previous1 2Next

Showing 1 to 50 of 73 entries

Insider Reports Filed by Fmr Llc

Symbol	Company	Period	Transactions	Value $	Form Type	Date Filed	Role
BEAM	Beam Therapeutics Inc.	Mar 31, 2025	0	$0	3	Apr 10, 2025	Other*, 10%+ Owner
GPCR	Structure Therapeutics Inc.	Feb 6, 2025	1	-$1.25K	4	Feb 10, 2025	Other*, 10%+ Owner
MTSR	Metsera, Inc.	Feb 3, 2025	4	$0	4	Feb 5, 2025	Other*, 10%+ Owner
MTSR	Metsera, Inc.	Jan 30, 2025	0	$0	3	Jan 30, 2025	Other*, 10%+ Owner
SANA	Sana Biotechnology, Inc.	Jan 8, 2025	4	-$1.89M	4	Jan 10, 2025	Other*, 10%+ Owner
BCAX	Bicara Therapeutics Inc.	Sep 16, 2024	6	$0	4	Sep 18, 2024	Other*
BCAX	Bicara Therapeutics Inc.	Sep 12, 2024	0	$0	3	Sep 12, 2024	Other*, 10%+ Owner
GPCR	Structure Therapeutics Inc.	Jun 6, 2024	0	$0	3	Jun 13, 2024	Other*, 10%+ Owner
GPCR	Structure Therapeutics Inc.	Apr 17, 2024	0	$0	4	Apr 19, 2024	Other*
SANA	Sana Biotechnology, Inc.	Apr 1, 2024	0	$0	3/A	Nov 21, 2024	Other*, 10%+ Owner
GPCR	Structure Therapeutics Inc.	Mar 14, 2024	1	-$770K	4	Mar 18, 2024	Other*, 10%+ Owner
BEAM	Beam Therapeutics Inc.	Feb 13, 2024	4	-$27.5M	4	Feb 15, 2024	Other*
GPCR	Structure Therapeutics Inc.	Feb 13, 2024	1	-$24.8K	4	Feb 15, 2024	Other*, 10%+ Owner
NONE	Fidelity Private Credit Fund	Jan 29, 2024	0	$0	4	Jan 31, 2024	Other*
TSBX	Turnstone Biologics Corp.	Jan 9, 2024	0	$0	4	Jan 11, 2024	Other*
BEAM	Beam Therapeutics Inc.	Dec 22, 2023	1	$0	4	Dec 27, 2023	Other*, 10%+ Owner
GPCR	Structure Therapeutics Inc.	Dec 22, 2023	1	$0	4	Dec 27, 2023	Other*, 10%+ Owner
GPCR	Structure Therapeutics Inc.	Dec 5, 2023	2	-$1.09M	4	Dec 7, 2023	Other*, 10%+ Owner
NONE	Fidelity Private Credit Fund	Nov 29, 2023	2	$20K	4	Nov 29, 2023	Other*, 10%+ Owner
GPCR	Structure Therapeutics Inc.	Oct 18, 2023	2	-$1.15M	4	Oct 23, 2023	Other*, 10%+ Owner
GPCR	Structure Therapeutics Inc.	Oct 2, 2023	0	$0	3	Oct 12, 2023	Other*, 10%+ Owner
NMRA	Neumora Therapeutics, Inc.	Sep 19, 2023	8	$0	4	Sep 21, 2023	Other*
NMRA	Neumora Therapeutics, Inc.	Sep 14, 2023	0	$0	3	Sep 14, 2023	Other*, 10%+ Owner
TSBX	Turnstone Biologics Corp.	Jul 25, 2023	12	$0	4	Jul 27, 2023	Other*, 10%+ Owner
TSBX	Turnstone Biologics Corp.	Jul 20, 2023	0	$0	3	Jul 20, 2023	Other*, 10%+ Owner
NONE	Fidelity Private Credit Fund	Jun 27, 2023	1	$8.75M	4	Jun 29, 2023	Other*, 10%+ Owner
NONE	Fidelity Multi-Strategy Credit Fund	May 19, 2023	0	$0	3	May 26, 2023	Other*, 10%+ Owner
NONE	Fidelity Private Credit Fund	Mar 13, 2023	0	$0	3	Mar 23, 2023	Other*, 10%+ Owner
GPCR	Structure Therapeutics Inc.	Feb 7, 2023	18	$0	4	Feb 9, 2023	Other*
GPCR	Structure Therapeutics Inc.	Feb 2, 2023	0	$0	3	Feb 2, 2023	Other*, 10%+ Owner
PRME	Prime Medicine, Inc.	Oct 24, 2022	10	$0	4	Oct 26, 2022	Other*
PRME	Prime Medicine, Inc.	Oct 19, 2022	0	$0	3	Oct 19, 2022	Other*, 10%+ Owner
BEAM	Beam Therapeutics Inc.	Sep 6, 2022	3	-$29.9K	4	Sep 8, 2022	Other*, 10%+ Owner
BEAM	Beam Therapeutics Inc.	Aug 4, 2022	9	-$1.23M	4	Aug 8, 2022	Other*, 10%+ Owner
VERV	Verve Therapeutics, Inc.	Jul 26, 2022	0	$0	4	Jul 28, 2022	Other*
VERV	Verve Therapeutics, Inc.	Jul 12, 2022	2	-$3.39M	4	Jul 14, 2022	Other*, 10%+ Owner
VERV	Verve Therapeutics, Inc.	Jul 1, 2022	1	-$607K	4	Jul 6, 2022	Other*, 10%+ Owner
VERV	Verve Therapeutics, Inc.	Jun 29, 2022	3	-$822K	4	Jul 1, 2022	Other*, 10%+ Owner
BEAM	Beam Therapeutics Inc.	Apr 12, 2022	11	-$981K	4	Apr 14, 2022	Other*, 10%+ Owner
VERV	Verve Therapeutics, Inc.	Mar 9, 2022	1	-$115K	4	Mar 11, 2022	Other*, 10%+ Owner
VERV	Verve Therapeutics, Inc.	Feb 9, 2022	1	-$389K	4	Feb 11, 2022	Other*, 10%+ Owner
VERV	Verve Therapeutics, Inc.	Feb 1, 2022	1	-$1.03M	4	Feb 3, 2022	Other*, 10%+ Owner
VERV	Verve Therapeutics, Inc.	Jan 26, 2022	5	-$4.94M	4	Jan 28, 2022	Other*, 10%+ Owner
BEAM	Beam Therapeutics Inc.	Jan 20, 2022	0	$0	3	Jan 24, 2022	Other*, 10%+ Owner
VERV	Verve Therapeutics, Inc.	Dec 23, 2021	0	$0	3	Dec 28, 2021	Other*, 10%+ Owner
TOST	Toast, Inc.	Nov 9, 2021	0	$0	4	Nov 12, 2021	Other*
XLO	Xilio Therapeutics, Inc.	Oct 26, 2021	10	$0	4	Oct 28, 2021	Other*
XLO	Xilio Therapeutics, Inc.	Oct 21, 2021	0	$0	3	Oct 21, 2021	Other*, 10%+ Owner
TOST	Toast, Inc.	Sep 24, 2021	0	$0	3	Oct 4, 2021	Other*, 10%+ Owner
BEAM	Beam Therapeutics Inc.	Aug 24, 2021	7	$0	4	Aug 26, 2021	Other*
BEAM	Beam Therapeutics Inc.	Aug 6, 2021	7	$0	4/A	Aug 16, 2021	Other*, 10%+ Owner
RLYB	Rallybio Corp	Aug 2, 2021	2	$0	4	Aug 4, 2021	Other*
RLYB	Rallybio Corp	Jul 29, 2021	0	$0	3	Jul 29, 2021	Other*, 10%+ Owner
CRBU	Caribou Biosciences, Inc.	Jul 27, 2021	8	$0	4	Jul 29, 2021	Other*
CRBU	Caribou Biosciences, Inc.	Jul 22, 2021	0	$0	3	Jul 22, 2021	Other*, 10%+ Owner
VERV	Verve Therapeutics, Inc.	Jun 21, 2021	4	$0	4	Jun 23, 2021	Other*
VERV	Verve Therapeutics, Inc.	Jun 16, 2021	0	$0	3	Jun 16, 2021	Other*, 10%+ Owner
FLYW	Flywire Corp	May 28, 2021	10	$0	4	Jun 2, 2021	Other*
FLYW	Flywire Corp	May 25, 2021	0	$0	3	May 26, 2021	Other*, 10%+ Owner